MedPath

Arsenicum Sulphuratum Flavum 3X as an adjunct to Individualized Homoeopathic Medicine in the treatment of Vitiligo

Not Applicable
Conditions
Health Condition 1: L80- Vitiligo
Registration Number
CTRI/2024/05/067563
Lead Sponsor
ehru Homoeopathic Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.At least 1 vitiligo skin lesion measuring at least 2x2cm in size.

2. Subjects suffering from vitiligo for at least 03 months.

3.Providing written informed consent.

4.Patients using oral/topical agents for Vitiligo will be included after a washout period of two weeks.

5.Patients with known but controlled systemic diseases.

Exclusion Criteria

•Vitiligo universalis

•Patients who are too sick for consultation and not willing to cooperate Unwilling to take part and not giving consent to join the study.

•Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure.

•Pregnant and Lactating women

•Uncontrolled Diabetes, Hypertension, Mental illness or depression, kidney or heart disease

• Substance abuse and/or dependence.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Vitiligo Area Scoring Index (VASI)Timepoint: At baseline and every month till one year
Secondary Outcome Measures
NameTimeMethod
Vitiligo Quality of Life Index (VitiQoL) questionnaireTimepoint: At baseline and every month till one year
© Copyright 2025. All Rights Reserved by MedPath